PB
Psyence Biomedical Ltd.
PBM · NASDAQ
$5.40 +8.65% (+$0.43)
1M +49.58%
Market Cap $102.7K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.01x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 58.93%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 36.81%
ROA 39.48%
Asset turnover 0.00x
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 14.62x
Int. coverage -727.46x
Stability
6 /100
Unstable Beta 1.72x
EPS volatility 666.33%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PBM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jody Aufrichtig
Employees
12
Headquarters
Toronto